Published in Proc Natl Acad Sci U S A on August 03, 1999
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci U S A (2003) 12.91
High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem (2011) 10.11
Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets. Cell (2015) 6.38
Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci U S A (2011) 6.29
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00
Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci U S A (2006) 5.21
Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol (2014) 4.76
Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods (2011) 4.18
Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem (2011) 4.14
Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med (2012) 3.92
Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods (2013) 3.63
Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One (2013) 3.53
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin Cancer Res (2014) 3.28
Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A (2007) 3.13
Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS One (2008) 2.79
Digital genotyping and haplotyping with polymerase colonies. Proc Natl Acad Sci U S A (2003) 2.77
Single-molecule approaches to stochastic gene expression. Annu Rev Biophys (2009) 2.75
Digital PCR provides sensitive and absolute calibration for high throughput sequencing. BMC Genomics (2009) 2.60
Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes. Proc Natl Acad Sci U S A (2012) 2.59
High-throughput quantitative polymerase chain reaction in picoliter droplets. Anal Chem (2008) 2.48
Development and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections. J Clin Microbiol (2013) 2.46
Genomic sequencing of uncultured microorganisms from single cells. Nat Rev Microbiol (2012) 2.45
Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus. J Clin Microbiol (2012) 2.39
Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol (2009) 2.34
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients. Oncotarget (2011) 2.34
Studying copy number variations using a nanofluidic platform. Nucleic Acids Res (2008) 2.23
Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol (2002) 2.18
COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. Clin Chem (2009) 2.17
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol (2015) 2.12
Digital MDA for enumeration of total nucleic acid contamination. Nucleic Acids Res (2010) 2.02
Counting individual DNA molecules by the stochastic attachment of diverse labels. Proc Natl Acad Sci U S A (2011) 1.89
Hybridization kinetics and thermodynamics of molecular beacons. Nucleic Acids Res (2003) 1.88
The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J Biol Chem (2008) 1.83
Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov (2014) 1.77
Viral diagnostics in the era of digital polymerase chain reaction. Diagn Microbiol Infect Dis (2012) 1.72
Miniaturized PCR chips for nucleic acid amplification and analysis: latest advances and future trends. Nucleic Acids Res (2007) 1.69
Linear-after-the-exponential (LATE)-PCR: an advanced method of asymmetric PCR and its uses in quantitative real-time analysis. Proc Natl Acad Sci U S A (2004) 1.69
PCR-based methods for the enrichment of minority alleles and mutations. Clin Chem (2009) 1.65
Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 1.64
Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing. Genome Biol (2011) 1.60
Digital PCR on a SlipChip. Lab Chip (2010) 1.57
Structure-function relationships of shared-stem and conventional molecular beacons. Nucleic Acids Res (2002) 1.51
Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral load. J Am Chem Soc (2011) 1.51
Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. Am J Obstet Gynecol (2009) 1.50
Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res (2000) 1.49
A new method for accurate assessment of DNA quality after bisulfite treatment. Nucleic Acids Res (2007) 1.46
Whole-genome haplotyping by dilution, amplification, and sequencing. Proc Natl Acad Sci U S A (2013) 1.44
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res (2008) 1.42
Application of Stochastic Labeling with Random-Sequence Barcodes for Simultaneous Quantification and Sequencing of Environmental 16S rRNA Genes. PLoS One (2017) 1.39
How many mutations in a cancer? Am J Pathol (2002) 1.37
Digital isothermal quantification of nucleic acids via simultaneous chemical initiation of recombinase polymerase amplification reactions on SlipChip. Anal Chem (2011) 1.36
Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res (2002) 1.33
Theoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfluidic digital PCR. Anal Chem (2011) 1.32
Nanoliter multiplex PCR arrays on a SlipChip. Anal Chem (2010) 1.30
BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res (2008) 1.30
High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR. Anal Chem (2014) 1.29
Molecular indexing enables quantitative targeted RNA sequencing and reveals poor efficiencies in standard library preparations. Proc Natl Acad Sci U S A (2014) 1.26
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol (2015) 1.22
Advances in microfluidic PCR for point-of-care infectious disease diagnostics. Biotechnol Adv (2011) 1.22
Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering. Nat Nanotechnol (2014) 1.18
Virtual microfluidics for digital quantification and single-cell sequencing. Nat Methods (2016) 1.16
DNA copy number concentration measured by digital and droplet digital quantitative PCR using certified reference materials. Anal Bioanal Chem (2015) 1.16
Evaluation of digital PCR for absolute RNA quantification. PLoS One (2013) 1.13
External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data. Nucleic Acids Res (2009) 1.11
Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer. J Cancer Res Clin Oncol (2013) 1.11
Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn (2004) 1.11
Digital PCR to detect and quantify heteroresistance in drug resistant Mycobacterium tuberculosis. PLoS One (2013) 1.11
Selection of reference genes for qPCR- and ddPCR-based analyses of gene expression in Senescing Barley leaves. PLoS One (2015) 1.10
Digital LAMP in a sample self-digitization (SD) chip. Lab Chip (2012) 1.08
Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR. Hum Gene Ther Methods (2014) 1.08
Comparative evaluation of three commercial quantitative cytomegalovirus standards by use of digital and real-time PCR. J Clin Microbiol (2015) 1.07
Molecular haplotyping by linking emulsion PCR: analysis of paraoxonase 1 haplotypes and phenotypes. Nucleic Acids Res (2005) 1.06
Single-cell multiplex gene detection and sequencing with microfluidically generated agarose emulsions. Angew Chem Int Ed Engl (2011) 1.06
Homogeneous point mutation detection by quantum dot-mediated two-color fluorescence coincidence analysis. Nucleic Acids Res (2006) 1.03
A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res (2008) 1.02
Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction. BMC Biotechnol (2003) 1.02
Evaluation of droplet digital PCR for characterizing plasmid reference material used for quantifying ammonia oxidizers and denitrifiers. Anal Bioanal Chem (2014) 1.01
Impact of variance components on reliability of absolute quantification using digital PCR. BMC Bioinformatics (2014) 1.01
Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications. Genome Biol (2016) 1.00
Droplet microfluidics for amplification-free genetic detection of single cells. Lab Chip (2012) 1.00
Multicolor combinatorial probe coding for real-time PCR. PLoS One (2011) 1.00
Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. Am J Epidemiol (2014) 1.00
Digital quantitation of potential therapeutic target RNAs. Nucleic Acid Ther (2013) 0.99
Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenetics Chromatin (2008) 0.99
Comparison of four digital PCR platforms for accurate quantification of DNA copy number of a certified plasmid DNA reference material. Sci Rep (2015) 0.98
Digital PCR: A brief history. Biomol Detect Quantif (2014) 0.98
Petri dish PCR: laser-heated reactions in nanoliter droplet arrays. Lab Chip (2009) 0.97
Quantification of Plasma miRNAs by Digital PCR for Cancer Diagnosis. Biomark Insights (2013) 0.96
Methods of molecular analysis: mutation detection in solid tumours. Mol Pathol (2002) 0.96
Brain tumor mutations detected in cerebral spinal fluid. Clin Chem (2015) 0.96
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. Nat Genet (2015) 0.95
Nanodroplet real-time PCR system with laser assisted heating. Opt Express (2009) 0.95
A single molecule array for digital targeted molecular analyses. Nucleic Acids Res (2008) 0.95
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. J Virol (2007) 0.94
Digital PCR modeling for maximal sensitivity, dynamic range and measurement precision. PLoS One (2015) 0.94
Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One (2010) 0.94
The potential impact of droplet microfluidics in biology. Anal Chem (2013) 0.94
Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data. Mov Disord (2013) 0.94
Real time quantitative PCR. Genome Res (1996) 35.79
Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol (1996) 21.49
Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature (1986) 17.77
Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature (1988) 10.84
Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet (1998) 9.84
Multicolor molecular beacons for allele discrimination. Nat Biotechnol (1998) 9.40
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A (1992) 9.15
Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res (1993) 6.33
Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res (1992) 5.98
Allelotype of colorectal carcinomas. Science (1989) 5.54
Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res (1999) 4.59
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. PCR Methods Appl (1992) 3.42
Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A (1996) 3.38
Haplotype of multiple polymorphisms resolved by enzymatic amplification of single DNA molecules. Proc Natl Acad Sci U S A (1990) 3.11
Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal (1999) 2.99
Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med (1996) 2.95
Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (1992) 2.80
Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene (1989) 2.67
Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res (1993) 2.22
Using PCR in preimplantation genetic disease diagnosis. Hum Reprod (1991) 2.18
Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res (1989) 2.04
Nucleic acid-based methods for the detection of cancer. Science (1997) 1.80
Genotyping by mass spectrometric analysis of short DNA fragments. Nat Biotechnol (1998) 1.76
Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst (1995) 1.70
Activation of ras oncogenes preceding the onset of neoplasia. Science (1990) 1.68
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res (1994) 1.68
Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. Biotechniques (1998) 1.63
Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene (1991) 1.59
Mutation processes at human minisatellites. Electrophoresis (1995) 1.55
TaqStart Antibody: "hot start" PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques (1994) 1.54
Genetic and functional changes in mitochondria associated with aging. Physiol Rev (1997) 1.42
Probing DNA sequences in solution with a monomer-excimer fluorescence color change. Nucleic Acids Res (1998) 1.36
Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research. Cytometry (1998) 1.20
Nucleotide analogs facilitate base conversion with 3' mismatch primers. Nucleic Acids Res (1999) 1.20
Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut (1995) 1.20
A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res (1995) 1.19
A homogeneous method for genotyping with fluorescence polarization. Clin Chem (1997) 1.17
Advances in approaches to DNA-based diagnostics. Curr Opin Biotechnol (1998) 1.17
Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res (1994) 1.16
p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg (1994) 1.15
Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance. Genome Res (1996) 1.12
Age-associated alterations of the mitochondrial genome. Free Radic Biol Med (1997) 1.10
Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood (1989) 1.09
Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia. Blood (1989) 1.06
Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens. J Invest Dermatol (1999) 1.02
Minisatellite "isoallele" discrimination in pseudohomozygotes by single molecule PCR and variant repeat mapping. Genomics (1991) 0.99
A nonradioactive, allele-specific polymerase chain reaction for reproducible detection of rare mutations in large amounts of genomic DNA: application to human k-ras. Anal Biochem (1997) 0.98
Using the polymerase chain reaction to estimate mutation frequencies and rates in human cells. Mutat Res (1992) 0.97
Mutational analysis of human NRAS genes in malignant melanoma: rapid methods for oligonucleotide hybridization and manual and automated direct sequencing of products generated by the polymerase chain reaction. Genes Chromosomes Cancer (1990) 0.96
High sensitive DNA typing approaches for the analysis of forensic evidence: comparison of nested variable number of tandem repeats (VNTR) amplification and a short tandem repeats (STR) polymorphism. Forensic Sci Int (1994) 0.93
Diagnostic detection of mutant ras genes in minor cell populations. Methods Enzymol (1995) 0.92
Amplification refractory mutation system linear extension: a novel, gel-free, enzyme-linked immunoassay method for DNA genotyping. Diagn Mol Pathol (1998) 0.92
Serial analysis of gene expression. Science (1995) 60.15
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 24.61
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (1997) 22.80
Genetic instabilities in human cancers. Nature (1998) 22.76
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Definition of a consensus binding site for p53. Nat Genet (1992) 12.76
Genetic instability in colorectal cancers. Nature (1997) 12.51
A model for p53-induced apoptosis. Nature (1997) 11.38
Characterization of the yeast transcriptome. Cell (1997) 11.33
Mutations of mitotic checkpoint genes in human cancers. Nature (1998) 11.20
Genes expressed in human tumor endothelium. Science (2000) 10.75
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (1992) 10.12
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
A public database for gene expression in human cancers. Cancer Res (1999) 8.81
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell (2001) 7.95
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (1993) 7.90
p53 function and dysfunction. Cell (1992) 7.73
14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell (1997) 7.20
Association of the APC tumor suppressor protein with catenins. Science (1993) 7.17
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (1992) 6.73
p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res (1995) 6.66
Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61
Identification of p53 as a sequence-specific DNA-binding protein. Science (1991) 6.60
Analysis of human transcriptomes. Nat Genet (1999) 6.14
Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest (1999) 6.13
The multistep nature of cancer. Trends Genet (1993) 6.12
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (1996) 6.11
Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell (1998) 5.88
Cancer-susceptibility genes. Gatekeepers and caretakers. Nature (1997) 5.87
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res (1998) 5.80
14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature (1999) 5.44
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res (1995) 5.26
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell (1999) 5.12
Role of BAX in the apoptotic response to anticancer agents. Science (2000) 5.07
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet (1998) 4.67
Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res (1992) 4.21
Identification of an amplified, highly expressed gene in a human glioma. Science (1987) 4.21
Genetic instability and darwinian selection in tumours. Trends Cell Biol (1999) 4.12
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
APC binds to the novel protein EB1. Cancer Res (1995) 3.98
Breast cancer. What's mice got to do with it? Nature (1996) 3.86
A phosphatase associated with metastasis of colorectal cancer. Science (2001) 3.86
Securin is required for chromosomal stability in human cells. Cell (2001) 3.71
Combinatorial chemoprevention of intestinal neoplasia. Nat Med (2000) 3.66
Scrambled exons. Cell (1991) 3.65
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci U S A (2000) 3.38
Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci U S A (1994) 3.36
Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res (2001) 3.29
Conversion of diploidy to haploidy. Nature (2000) 3.28
Mutations of GTBP in genetically unstable cells. Science (1995) 3.23
Identification and classification of p53-regulated genes. Proc Natl Acad Sci U S A (1999) 3.07
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A (1997) 3.03
Deletion of p16 and p15 genes in brain tumors. Cancer Res (1994) 3.03
p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res (1993) 2.99
CpG methylation is maintained in human cancer cells lacking DNMT1. Nature (2000) 2.94
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A (1998) 2.83
Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev (1996) 2.81
Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A (1996) 2.75
Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res (1994) 2.65
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res (2001) 2.65
Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A (2001) 2.62
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Use of isogenic human cancer cells for high-throughput screening and drug discovery. Nat Biotechnol (2001) 2.59
The GLI-Kruppel family of human genes. Mol Cell Biol (1988) 2.52
Mad-related genes in the human. Nat Genet (1996) 2.51
Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med (2001) 2.47
In vivo cloning of PCR products in E. coli. Nucleic Acids Res (1993) 2.40
Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med (1995) 2.40
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18
Allelotype of pancreatic adenocarcinoma. Cancer Res (1994) 2.11
Association between wild type and mutant APC gene products. Cancer Res (1993) 2.08
Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A (2001) 2.06
Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics (1999) 2.01
Mutant p53 proteins bind DNA abnormally in vitro. Oncogene (1991) 1.96
Characterization of human FAST-1, a TGF beta and activin signal transducer. Mol Cell (1998) 1.90
A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res (1995) 1.86
Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res (1994) 1.82
p53 tagged sites from human genomic DNA. Hum Mol Genet (1994) 1.82
Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev (2000) 1.80
Expression of the APC tumor suppressor protein in oligodendroglia. Glia (1996) 1.77